Skip to content

Extracellular Vesicles as Biomarkers for Chronic Renal Failure

Extracellular Vesicles as Biomarkers for Chronic Renal Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04700631
Acronym
VE-IRC
Enrollment
143
Registered
2021-01-08
Start date
2021-01-01
Completion date
2023-07-01
Last updated
2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure, Urinary Extracellular Vesicle

Keywords

urinary extracellular vesicle, Chronic Renal Failure

Brief summary

The recent discovery of extracellular vesicles (EV) as a mechanism of intercellular communication has made it possible to develop a new field of health research and could bring new information on the pathological mechanisms of renal diseases. Definition of physiologic and pathologic values of urinary extracellular vesicles (EVu) between healthy subjects and chronic kidney diseases (CKD) patients could be a new tool for follow up of renal diseases. EV are found in all biological fluids including urine, that's why they are increasingly analyzed in renal pathologies. The main objective of this study is to determine the physiological values and the pathological thresholds of EVu.

Interventions

DIAGNOSTIC_TESTurinary extracellular vesicle concentration

urinary extracellular vesicle concentration will be determined in urine samples from CRF and healthy patients

DIAGNOSTIC_TESTblood sample

blood sample in order to determine creatin level

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* subject \> 18 years old * healthy subjects : no medical history, in particular cardiovascular, without drug treatment, without proteinuria, normal BMI * CRF patients : eGFR estimated according to the MRDR formula less than 89 mL/min/1,73m²

Exclusion criteria

* patients under dialysis protocols * renal transplant patients

Design outcomes

Primary

MeasureTime frameDescription
variation of urinary extracellular vesicle concentration between both groupsone dayvariation of urinary extracellular vesicle concentration between both groups : healthy and CRF patients Urinary extracellular vesicle concentrations will be measured as number of extracellular vesicles per mL of urine

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026